查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403391

2030 年总体基因体学市场预测：按产品类型、技术、应用、最终用户和地区进行的全球分析

Metagenomics Market Forecasts to 2030 - Global Analysis By Product Type (Kits & Reagents, Software, Sequencing & Data Analytics Services and Other Product Types), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球总体基因体学市场规模将达20亿美元，预计在预测期内复合年增长率为18.5%，到2030年将达到65亿美元。

从环境样本中提取遗传物质的研究称为总体基因体学。这项研究的特点是作为微生物群落研究遗传和微生物途径的工具。这提供了一个强大的镜头，能够理解整个生命宇宙。科技使研究人员能够接触到各种各样的微生物，使他们能够更好地了解微生物生态系统。

根据美国国家人类基因组研究所截至 2017 年 7 月的报告，对一个人类基因组序列测定大约需要 743 Terabyte(743,000 GB) 的资料，而 2001 年人类基因计划启动时将产生 16.2 GB 的数据。

临床应用需求不断增加

总体基因体学在疾病诊断、个人化医疗以及了解人类微生物组在健康和疾病中的作用的临床实践中正在取得进展。它能够对微生物群落进行全面分析，有助于疾病识别、治疗优化和药物开发。这些生物标记有潜力作为各种疾病的诊断指标和治疗标靶。这些都是推动市场成长的因素。

道德和监管问题

敏感资讯的管理引起了必须解决的道德和隐私问题，特别是与人类微生物组资料的使用相关的问题。此外，管理遗传和资料使用的法律的地区差异资料商业化和研究倡议。此外，管理、储存和解读此类资料可能很困难，并且需要专业知识，这可能会进一步阻碍市场扩张。

提高意识和研究倡议

人们越来越关注微生物组对农业、人类健康和环境的影响，导致资金筹措和研究计划的增加。由于技术和分析技术的进步，总体基因体学学领域正在迅速发展。由于新的发现和见解，我们对微生物群落的了解不断增长。由于政府机构、学术机构和商业公司的资助不断增加，宏基因组研究市场正在不断成长。

与定序技术相关的高成本

资料分析、电脑资源和定序技术的高昂成本是小型研究机构和预算有限的公司使用它们的主要障碍。宏基因组研究产生大量资料，需要先进的计算基础设施和生物资讯知识。评估各种微生物群落的挑战之一是它们的复杂性。这是阻碍市场拓展的因素。

COVID-19 的影响：

借助总体基因体学，识别并检测到了导致 COVID-19 的 SARS-CoV-2。研究人员利用宏基因组分析来追踪突变、发现新病毒株并了解病毒的传播。总体基因体学对于製造疫苗很有用，因为它揭示了病毒的基因组成。科学家们正在利用这些知识，透过更好地了解病毒如何随时间变化并开发免疫接种来提高疫苗的有效性。

套件和试剂部分预计将在预测期内成为最大的部分

套件和试剂部分预计将成为预测期内最大的部分。这些套件提供标准化的方法和试剂，以确保实验过程的一致性和重现性。这减少了实验和研究之间的差异。这些套件效果更好，因为它们是针对特定样本类型和定序平台量身定制的。许多零件专为困难样品而设计，可提高 DNA产量和纯度。

预测期内，鸟枪定序领域预估复合年增长率最高

预计鸟枪测序产业在预测期内将经历最高的复合年增长率。鸟枪法定序是公平的，因为它不需要事先了解样本中存在的物种。因为它捕获了所有遗传资讯，所以可以发现新的和意想不到的物种。它有助于为更有针对性的研究提出假设。透过识别群落的遗传潜力，研究人员可以专注于感兴趣的特定基因和途径进行详细研究。

占比最大的地区：

预计北美在预测期内将占据最大的市场占有率。在这些栖息地中，透过总体基因体学对遗传多样性进行广泛分析有助于了解存在的各种生物体。该地区处于技术进步的前沿。定序和计算技术的技术发展允许对复杂的微生物种群进行更深入的探索和理解，从而促进了宏基因组研究。

复合年增长率最高的地区：

预计亚太地区在预测期内将维持最高的复合年增长率。在中国、印度和日本等国家，调查土壤健康、发现对农业有用的微生物以及解决河流和海洋污染等环境问题，都透过总体基因体学的使用而得到促进。总体基因体学在了解人口稠密的大都会圈发现的微生物群落、促进疾病监测和检查人类微生物组的多样性方面发挥着重要作用。

  • 其他产品类型

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球总体基因体学市场：依产品类型

  • 套件和试剂
  • 软体
  • 定序和资料分析服务
  • 文库製备试剂套件
  • 样品萃取套件
  • 宏基因组定序试剂套件
  • 其他产品类型

第六章全球总体基因体学市场：依技术分类

  • 16S序列
  • 全基因组序列测定
  • 霰弹枪序列
  • 元转录组学
  • 其他技术

第七章全球总体基因体学市场：依应用分类

  • 介面活性剂和抗生素的生产
  • 临床诊断
  • 微生物多样性
  • 生物修復和降解
  • 其他用途

第八章全球总体基因体学市场：依最终用户分类

  • 病理实验室
  • 学术研究所
  • 调查
  • 生物技术
  • 药品
  • 食品和营养
  • 其他最终用户

第九章全球总体基因体学市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Agilent Technologies
  • BGI Group
  • Bio-Rad Laboratories
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • IntegraGen
  • Merck KGaA
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • PerkinElmer, Inc.
  • Promega Corporation
  • Qiagen
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trivitron Healthcare Pvt. Ltd.
Product Code: SMRC24616

According to Stratistics MRC, the Global Metagenomics Market is accounted for $2.0 billion in 2023 and is expected to reach $6.5 billion by 2030 growing at a CAGR of 18.5% during the forecast period. The study of genetic material extracted from environmental samples is known as metagenomics. To investigate genes and microbial pathways, the research is characterized as a tool for the microbial community. It offers a strong lens with the capacity to comprehend the entirety of the living universe. Researchers may now access a wide range of microbial variety and gain a better grasp of the microbial ecology thanks to technology.

According to a report from the National Human Genome Research Institute as of July 2017, approximately 743 terabytes (743,000 gigabytes) of data are generated during the sequencing of a single human genome, compared to 16.2 gigabytes at the beginning of the human genome project in 2001.

Market Dynamics:

Driver:

Rising demand in clinical applications

Metagenomics has gained traction in clinical settings for disease diagnostics, personalized medicine, and understanding the human microbiome's role in health and disease. It allows for comprehensive analysis of microbial communities, aiding in disease identification, treatment optimization, and drug development. These biomarkers could potentially serve as diagnostic indicators or therapeutic targets for various conditions. These are the factors propelling the growth of the market.

Restraint:

Ethical and regulatory concerns

The management of sensitive information raises ethical and privacy concerns that must be addressed, particularly with relation to the use of human microbiome data. Furthermore, regional differences in the laws governing the use of genetic and microbiological data have an effect on commercialization and research initiatives. Furthermore, managing, preserving, and deciphering this data might be difficult and call for specific knowledge, which could further impede the market's expansion.

Opportunity:

Increasing awareness and research initiatives

Growing apprehension about the effects of microbiomes on agriculture, human health, and the environment has resulted in more financing and research projects. The area of metagenomics is developing quickly due to ongoing advances in technology and analytical techniques. The understanding of microbial communities is always growing as a result of new findings and insights. The market for metagenomics research is growing as a result of increased funding from governmental bodies, academic institutions, and commercial businesses.

Threat:

High costs associated with sequencing technologies

The high expense of data analysis, computer resources, and sequencing technology is a major hurdle that prevents smaller research organizations or businesses with tighter budgets from using them. Metagenomic investigations create enormous amounts of data, which calls for advanced computing infrastructure and bioinformatics knowledge. One of the challenges in evaluating various microbial communities is their complexity. This is the element impeding the market's expansion.

COVID-19 Impact:

us that causes COVID-19, SARS-CoV-2, has been identified and detected thanks in large part to metagenomics. Metagenomic sequencing has been utilized by researchers to track mutations, find new strains, and comprehend the virus's dissemination. Because it sheds light on the virus's genetic composition, metagenomics has aided in the creation of vaccines. Scientists have used this knowledge to better understand how the virus could change over time and develop vaccinations, which has improved vaccine effectiveness.

The kits & reagents segment is expected to be the largest during the forecast period

The kits & reagents segment is expected to be the largest during the forecast period. Standardized methods and reagents are provided by these kits, guaranteeing uniformity and repeatability in experimental processes. This lessens variation across experiments and amongst researchers. These kits work better because they are tailored for particular kinds of samples or sequencing platforms. They frequently have parts designed specifically for difficult sample kinds, enhancing DNA yield and purity.

The shotgun sequencing segment is expected to have the highest CAGR during the forecast period

The shotgun sequencing segment is expected to have the highest CAGR during the forecast period. Without requiring prior knowledge of the species present in the sample, shotgun sequencing is impartial. Since it captures all genetic information, new and unexpected species can be found. It helps to produce hypotheses for more focused research. Researchers might concentrate on particular genes or pathways of interest for in-depth studies by identifying a community's genetic potential.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Understanding the wide variety of organisms present is made easier by the extensive analysis of genetic diversity provided by metagenomics in these habitats. The area is leading the way in technical advancements. Technological developments in sequencing and computational techniques facilitate metagenomic research by enabling deeper examination and comprehension of intricate microbial populations.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. Researching soil health, discovering useful microbes for agriculture, and addressing environmental issues like pollution in rivers and seas in nations such as China, India, and Japan are all made easier by the use of metagenomics. Metagenomics plays a crucial role in comprehending the microbial communities found in highly populated metropolitan regions, facilitating disease surveillance, and examining the variety of the human microbiome.

Key players in the market:

Some of the key players in Metagenomics market include Agilent Technologies, BGI Group, Bio-Rad Laboratories, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Illumina, Inc., IntegraGen, Merck KGaA, Novogene Co., Ltd., Oxford Nanopore Technologies, PerkinElmer, Inc., Promega Corporation, Qiagen, Takara Bio, Inc., Thermo Fisher Scientific, Inc. and Trivitron Healthcare Pvt. Ltd.

Key Developments:

In September 2022, Illumina, Inc. (US) launched the NovaSeq X series production-scale sequencers, which are capable of generating more than 20,000 whole genomes per year (which is 2.5 times the throughput of prior sequencers from Illumina).

In September 2021, Thermo Fisher Scientific, Inc. (US) and AstraZeneca(UK) co-developed an NGS-based companion diagnostic. The collaboration was focused on commercializing NGS-based diagnostics in Russia.

Product Types Covered:

  • Kits & Reagents
  • Software
  • Sequencing & Data Analytics Services

Library Preparation Kits

Sample Extraction Kits

Metagenomic Sequencing Kits

  • Other Product Types

Technologies Covered:

  • 16S Sequencing
  • Whole Genome Sequencing
  • Shotgun Sequencing
  • Metatranscriptomics
  • Other Technologies

Applications Covered:

  • Bio Surfactants and Antibiotics Production
  • Clinical Diagnostics
  • Microbial Diversity
  • Bioremediation and Degradation
  • Other Applications

End Users Covered:

  • Pathology Laboratories
  • Academic and Research Institutes
  • Biotechnology
  • Pharmaceutical
  • Food & Nutrition
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Metagenomics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Kits & Reagents
  • 5.3 Software
  • 5.4 Sequencing & Data Analytics Services
  • 5.5 Library Preparation Kits
  • 5.6 Sample Extraction Kits
  • 5.7 Metagenomic Sequencing Kits
  • 5.8 Other Product Types

6 Global Metagenomics Market, By Technology

  • 6.1 Introduction
  • 6.2 16S Sequencing
  • 6.3 Whole Genome Sequencing
  • 6.4 Shotgun Sequencing
  • 6.5 Metatranscriptomics
  • 6.6 Other Technologies

7 Global Metagenomics Market, By Application

  • 7.1 Introduction
  • 7.2 Bio Surfactants and Antibiotics Production
  • 7.3 Clinical Diagnostics
  • 7.4 Microbial Diversity
  • 7.5 Bioremediation and Degradation
  • 7.6 Other Applications

8 Global Metagenomics Market, By End User

  • 8.1 Introduction
  • 8.2 Pathology Laboratories
  • 8.3 Academic and Research Institutes
  • 8.4 Research Laboratories
  • 8.5 Biotechnology
  • 8.6 Pharmaceutical
  • 8.7 Food & Nutrition
  • 8.8 Other End Users

9 Global Metagenomics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies
  • 11.2 BGI Group
  • 11.3 Bio-Rad Laboratories
  • 11.4 Eurofins Scientific
  • 11.5 F. Hoffmann-La Roche Ltd.
  • 11.6 Illumina, Inc.
  • 11.7 IntegraGen
  • 11.8 Merck KGaA
  • 11.9 Novogene Co., Ltd.
  • 11.10 Oxford Nanopore Technologies
  • 11.11 PerkinElmer, Inc.
  • 11.12 Promega Corporation
  • 11.13 Qiagen
  • 11.14 Takara Bio, Inc.
  • 11.15 Thermo Fisher Scientific, Inc.
  • 11.16 Trivitron Healthcare Pvt. Ltd.

List of Tables

  • Table 1 Global Metagenomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Metagenomics Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Metagenomics Market Outlook, By Kits & Reagents (2021-2030) ($MN)
  • Table 4 Global Metagenomics Market Outlook, By Software (2021-2030) ($MN)
  • Table 5 Global Metagenomics Market Outlook, By Sequencing & Data Analytics Services (2021-2030) ($MN)
  • Table 6 Global Metagenomics Market Outlook, By Library Preparation Kits (2021-2030) ($MN)
  • Table 7 Global Metagenomics Market Outlook, By Sample Extraction Kits (2021-2030) ($MN)
  • Table 8 Global Metagenomics Market Outlook, By Metagenomic Sequencing Kits (2021-2030) ($MN)
  • Table 9 Global Metagenomics Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 10 Global Metagenomics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 11 Global Metagenomics Market Outlook, By 16S Sequencing (2021-2030) ($MN)
  • Table 12 Global Metagenomics Market Outlook, By Whole Genome Sequencing (2021-2030) ($MN)
  • Table 13 Global Metagenomics Market Outlook, By Shotgun Sequencing (2021-2030) ($MN)
  • Table 14 Global Metagenomics Market Outlook, By Metatranscriptomics (2021-2030) ($MN)
  • Table 15 Global Metagenomics Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 16 Global Metagenomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Metagenomics Market Outlook, By Bio Surfactants and Antibiotics Production (2021-2030) ($MN)
  • Table 18 Global Metagenomics Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 19 Global Metagenomics Market Outlook, By Microbial Diversity (2021-2030) ($MN)
  • Table 20 Global Metagenomics Market Outlook, By Bioremediation and Degradation (2021-2030) ($MN)
  • Table 21 Global Metagenomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 22 Global Metagenomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 23 Global Metagenomics Market Outlook, By Pathology Laboratories (2021-2030) ($MN)
  • Table 24 Global Metagenomics Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 25 Global Metagenomics Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 26 Global Metagenomics Market Outlook, By Biotechnology (2021-2030) ($MN)
  • Table 27 Global Metagenomics Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 28 Global Metagenomics Market Outlook, By Food & Nutrition (2021-2030) ($MN)
  • Table 29 Global Metagenomics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.